RALEIGH, N.C., June 9, 2017 /PRNewswire/ -- Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces
Wake's team in attendance includes: Ben Riedlinger, Associate Director of Business Development; Marion Peoples, Director Site Start-Up; McKenzie Finch, Business Development Associate; and Brennan Opanasenko, Site Start-Up Associate.
About Wake Research
Wake Research is an organization of unified investigational sites, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. Wake Research is fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications. Founded in 1984, Wake Research has more than 2,500 successful clinical trials and a combined subject database of nearly 950,000 individuals.
Wake Research is a unique and innovative resource, using the talents of 56 Principal Investigators for Phase I through Phase IV clinical trials specializing in gastroenterology, musculoskeletal disorders, metabolic disorders, dermatology, vaccines including bio-defense research, CNS/sleep disorders.
Wake Research is known for effectively combining strategic volunteer recruitment and retention with high quality clinical trial conduct, using centralized administration and standardized operating procedures
About the DIA
DIA, founded as the Drug Information Association, provides a global, neutral forum where stakeholders can openly and freely exchange knowledge information and insights beyond boundaries to advance innovation in health care product development and life cycle management globally.
The DIA Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. Themed "Driving Insights to Action," DIA 2017 will host more than 7,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe. DIA 2017 boasts more than 450 exhibiting companies, 10+ tracks, and more than 160 sessions.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wake-research-to-attend-the-drug-information-associations-dia-2017-annual-meeting-300471392.html
SOURCE Wake Research
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All